SOLIGENIX, INC. — Investor Relations & Filings
Filings indexed
1,023
across all filing types
Latest filing
2026-05-08
Regulatory Filings
Country
US
United States of America
Listing
US
SNGX
Soligenix, Inc. is a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases with unmet medical needs. The company operates through two main segments: Specialized BioTherapeutics and Public Health Solutions. The Specialized BioTherapeutics pipeline develops treatments for orphan diseases. The Public Health Solutions pipeline, funded by government grants and contracts, focuses on developing vaccines and therapeutics for infectious diseases and biodefense applications, including a program to prevent ricin poisoning.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 424B3 | 2026-05-08 | English | |
| 424B3 - SOLIGENIX, INC. (0000812796) (Filer) | 2026-05-08 | English | |
| 424B3 - SOLIGENIX, INC. (0000812796) (Filer) | 2026-05-08 | English | |
| 424B3 | 2026-05-08 | English | |
| 10-Q | 2026-05-08 | English | |
| 8-K - SOLIGENIX, INC. (0000812796) (Filer) | 2026-04-28 | English |
Browse filings by year
20 years- 2026 19 filings
- 2025 43 filings
- 2024 51 filings
- 2023 62 filings
- 2022 39 filings
- 2021 37 filings
- 2020 50 filings
- 2019 37 filings
- 2018 40 filings
- 2017 51 filings
- 2016 74 filings
- 2015 45 filings
- 2014 72 filings
- 2013 74 filings
- 2012 30 filings
- 2011 62 filings
- 2010 83 filings
- 2009 87 filings
- 2008 40 filings
- 2007 27 filings
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46108625 | 424B3 | 2026-05-08 | English | ||
| 44412999 | 424B3 - SOLIGENIX, INC. (0000812796) (Filer) | 2026-05-08 | English | ||
| 44412954 | 424B3 - SOLIGENIX, INC. (0000812796) (Filer) | 2026-05-08 | English | ||
| 46108658 | 424B3 | 2026-05-08 | English | ||
| 46108646 | 10-Q | 2026-05-08 | English | ||
| 37970936 | 8-K - SOLIGENIX, INC. (0000812796) (Filer) | 2026-04-28 | English | ||
| 46108626 | Regulatory Filings 2026 | 2026-04-03 | English | ||
| 46108647 | Regulatory Filings 2026 | 2026-04-03 | English | ||
| 46108650 | Regulatory Filings 2026 | 2026-04-03 | English | ||
| 46108653 | Regulatory Filings 2026 | 2026-04-03 | English | ||
| 46108683 | POS AM | 2026-03-31 | English | ||
| 46108724 | POS AM | 2026-03-31 | English | ||
| 46108775 | POS AM | 2026-03-31 | English | ||
| 46108837 | POS AM | 2026-03-31 | English | ||
| 46108913 | 10-K | 2026-03-31 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
ARGENT BIOPHARMA LIMITED
Develops plant-inspired and synthetic medicines for neurolo…
|
RGT | AU | Manufacturing |
|
argenx SE
Develops and commercializes antibody-based therapies for se…
|
1AE | NL | Manufacturing |
|
Armata Pharmaceuticals, Inc.
Develops bacteriophage therapeutics for antibiotic-resistan…
|
ARMP | US | Manufacturing |
|
AroCell AB
Develops and markets in vitro diagnostic (IVD) tests for on…
|
AROC | SE | Manufacturing |
|
ArriVent BioPharma, Inc.
Clinical-stage biopharma developing oncology drugs for diff…
|
AVBP | US | Manufacturing |
|
ARROWHEAD PHARMACEUTICALS, INC.
Biotechnology company developing RNAi therapies to treat in…
|
ARWR | US | Manufacturing |
|
ARS Pharmaceuticals, Inc.
Develops and commercializes needle-free products for admini…
|
SPRY | US | Manufacturing |
|
ARTELO BIOSCIENCES, INC.
Clinical-stage biopharma developing therapeutics by modulat…
|
ARTL | US | Manufacturing |
|
Arura Pharma Inc
Diversified manufacturer and distributor in consumer goods …
|
— | CA | Manufacturing |
|
Ascelia Pharma
Biotechnology company developing and commercializing novel …
|
ACE | SE | Manufacturing |
SOLIGENIX, INC. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35119/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35119 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35119 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35119 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35119}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for SOLIGENIX, INC. (id: 35119)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.